Pressure to Reduce IBNR and Certify a Solvency Ratio
The chief actuary of an Iranian non-life insurer is finalising the annual reserve report. The best-estimate IBNR is IRR 900,000 million. The CEO asks for it to be reduced to IRR 630,000 million (a 30% cut) so that the regulatory solvency ratio stays above 100%; otherwise the insurer must raise capital or stop writing new business. The claims department has just migrated to a new system, and 8% of claim notifications are missing from the extract. The CEO says the missing claims are probably small and offers a signed representation that no material claims exist. The audit committee meets tomorrow. The reserving standard requires a best estimate and disclosure of material uncertainty. The actuary also sits on the investment committee that bought a large illiquid holding, which could be sold to cover the capital gap.
1. Identify the ethical and professional issues and set out what the actuary should do before the audit committee meeting.
Read the worked answer
Ethical issues: (1) the actuary is being asked to set a reserve to a predetermined solvency outcome rather than the best estimate; (2) 8% of claim notifications are missing, so the data are materially incomplete; (3) a CEO representation does not replace claims data; (4) a possible conflict of interest because the actuary sits on the investment committee that holds the illiquid asset. The actuary should not reduce IBNR by 30% without a documented, data-based reason. Steps: quantify the missing claims using claims-development or reporting-delay analysis; present a range (e.g., 900,000m best estimate with a range of 850,000–1,000,000m); state that the 630,000m figure is outside the reasonable range; refuse to certify it; report the data limitation and the pressure to the audit committee; and disclose the investment-committee conflict, recusing from decisions about selling the asset if necessary.
2. Draft the key points the actuary should present to the audit committee, including how to handle the solvency gap and the illiquid asset.
Read the worked answer
Audit committee points:
- Best estimate and range, with the 8% missing notifications treated as a data limitation.
- Reconciliation of the 900,000m to the 630,000m request; show that the cut is not supported by any change in assumptions.
- Solvency gap and options: raise capital, reinsure, slow new business, sell the illiquid asset at a fair value, or seek regulatory forbearance. Do not close the gap by understating liabilities.
- Sensitivity: if missing claims are at the average cost, IBNR rises; if they are large, the gap widens.
- Governance: the CEO's signed representation should be recorded, but it does not cure the data deficiency.
- Conflict: the actuary's investment-committee role should be disclosed; an independent review of the asset valuation and sale may be appropriate.
- Communication: a qualified actuarial opinion or a report to the regulator may be required if the board proceeds.
3. What if the CEO threatens to replace the actuary? Explain the actuary's obligations and protections.
Read the worked answer
If the CEO threatens replacement, the actuary's obligation is to maintain the professional position and not sign a misleading reserve. The actuary should document the threat, keep a contemporaneous record of the data limitation and the advice, and escalate to the audit committee, the board, and if necessary the regulator or professional body. Replacing the actuary does not make the reserve adequate; the incoming actuary must be given the same facts. The actuary should also check the professional standards on whistleblowing and on responding to pressure. Resigning may be appropriate if the board certifies the misleading figure, but the actuary should first use internal escalation and preserve evidence.